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The epidermal permeability barrier is maintained by
extracellular lipid membranes within the interstices of
the stratum corneum. Ceramides, the major components
of these multilayered membranes, derive in large part
from hydrolysis of glucosylceramides mediated by stra-
tum corneum b-glucocerebrosidase (b-GlcCerase). Pro-
saposin (pSAP) is a large precursor protein that is pro-
teolytically cleaved to form four distinct sphingolipid
activator proteins, which stimulate enzymatic hydroly-
sis of sphingolipids, including glucosylceramide. Re-
cently, pSAP has been eliminated in a mouse model us-
ing targeted deletion and homologous recombination. In
addition to the extracutaneous findings noted previ-
ously, our present data indicate that pSAP deficiency in
the epidermis has significant consequences including: 1)
an accumulation of epidermal glucosylceramides to-
gether with below normal levels of ceramides; 2) alter-
ations in lipids that are bound by ester linkages to pro-
teins of the cornified cell envelope; 3) a thickened
stratum lucidum with evidence of scaling; and 4) a strik-
ing abnormality in lamellar membrane maturation
within the interstices of the stratum corneum. Together,
these results demonstrate that the production of pSAP,
and presumably mature sphingolipid activator protein
generation, is required for normal epidermal barrier
formation and function. Moreover, detection of signifi-
cant amounts of covalently bound v-OH-GlcCer in
pSAP-deficient epidermis suggests that deglucosylation
to v-OH-Cer is not a requisite step prior to covalent
attachment of lipid to cornified envelope proteins.
Sphingolipid activator proteins (SAPs1 or saposins) are non-
enzymatic glycoprotein cofactors required for lysosomal degra-
dation of various glycosphingolipids by exohydrolases (1, 2).
Proteolytic cleavage of SAP precursor (pSAP) in acidic compart-
ments releases four homologous polypeptides (i.e. SAP-A,
SAP-B, SAP-C, and SAP-D), thought to function either by di-
rect activation of their respective enzyme or as biological de-
tergents that lift substrates out of the membrane plane (3–5).
One of the activator proteins, SAP-C, has been shown to stim-
ulate lysosomal glucosylceramide (GlcCer) degradation by
b-glucocerebrosidase (b-GlcCerase) (6, 7). A deficiency of
SAP-C causes a variant form of Gaucher disease (8–10).
In terrestrial mammals, the permeability barrier that re-
stricts excess transepidermal water loss is maintained by
unique arrays of lamellar membranes localized in the inter-
stices of the outermost stratum corneum layer of the epidermis.
These lamellar arrays derive from the extruded lipid contents
of lamellar bodies after fusion of these organelles with the
apical plasma membrane of the outermost granular cell. The
initially secreted lipids are processed by a set of co-localized
lipid hydrolases into a more hydrophobic mixture, enriched in
ceramides (Cer). The resultant Cer, comprising a family of
compounds with complex chemical structures, together with
free fatty acids and cholesterol are the dominant constituents
of the stratum corneum (SC) lamellar membranes (11). Two of
these species, which possess an v-hydroxy moiety on the N-acyl
fatty acid, are covalently bound to structural proteins of the
cornified cell envelope forming a hydrophobic surface on termi-
nally differentiated keratinocytes (12, 13).
The postsecretory processing of lamellar body-derived Glc-
Cers to ceramides by b-GlcCerase is essential for maintenance
of permeability barrier homeostasis (14–17). Because SAP-C
stimulates lysosomal GlcCer degradation in vivo, it seems rea-
sonable to predict that expression of pSAP would also be im-
portant for epidermal barrier formation. Decreased levels of
pSAP have been detected in atopic skin, suggesting a role for
SAPs in epidermal function (18). Furthermore, a 20-week
pSAP-deficient human fetus, with a phenotype resembling
acute neuronopathic (type 2) Gaucher disease, displayed exten-
sive cutaneous lysosomal storage deposits and neutral glyco-
sphingolipid accumulation in dermal fibroblasts (19). A SAP
precursor-deficient mouse (pSAP 2/2) has recently been cre-
ated by targeted gene disruption and homologous recombina-
tion (20). Because of the deficiency of the complete precursor
protein, none of the four SAPs are generated in any cell type.
Initial characterization of these mice exhibited two distinct
phenotypes, i.e. neonatally fatal and later onset. The pathology
of the latter is complex, including severe hypomyelination and
storage of multiple sphingolipids in the brain (20, 21), as well
as an ichthyosiform dermatosis. Thus, in the present work, we
focused on the physiologic function of pSAP in the context of
cutaneous permeability barrier formation and investigated the
effects of pSAP deficiency on epidermal lipid composition and
structure.
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MATERIALS AND METHODS
Animals—Generation of SAP-deficient mice through targeted gene
disruption has been described previously (20). Newborn knockout mice
(homozygous, n 5 9; heterozygous, n 5 8) as well as newborn wild-type
littermates (n 5 7) were studied. Genotyping was performed by polym-
erase chain reaction. The primers used had the following sequence:
forward primer, 59-GCC CAC AGC GGT GAG TGC-39, matching on the
pSAP genomic DNA on exon 2/intron 2; reverse primer, 59-CAG-
CAA GTT CCC AGC TTC GG-39, matching on exon 3. With those prim-
ers a band of 1300 bp appeared in the pSAP 2/2 mice, a band of 806 bp
appeared in pSAP 1/1 mice, and both bands appeared in pSAP 1/2
mice.
Preparation of Epidermis—Whole skin was removed at autopsy from
newborn mice. Epidermis was separated from dermis after floating the
skin on Dispase (Boehringer Mannheim, grade II) diluted 1:1 in Hanks’
buffer at 4 °C overnight.
Lipid Analysis—Tissue samples were homogenized, lyophilized, and
weighed. Epidermal lipids were extracted for 24 h at 37 °C in each of
three solvent mixtures (chloroform/methanol/water 1:2:0.5 (v/v/v); chlo-
roform/methanol 1:1 (v/v), and chloroform/methanol 2:1 (v/v). Total lipid
extracts were applied to thin-layer Silica Gel 60 plates (Merck Darm-
stadt, Germany). All plates were washed with chloroform/methanol
(9:1, v/v) before sample application. For separation of glucosylceram-
ides, the chromatograms were developed with chloroform/methanol/
water (70:30:5, v/v/v). Ceramides were resolved twice using chloroform/
methanol/acetic acid (190:9:1, v/v/v) as developing solvent. For
quantitative analytical TLC determination, increasing amounts of
standard lipids (N-stearoyl-sphingosine (kind gift of Beiersdorf AG,
Hamburg, Germany), sphingomyelin (Sigma), and glucosylceramide
(purified from Gaucher spleen in our laboratory)) were applied. After
development, plates were air-dried, sprayed with 8% (w/v) H3PO4 con-
taining 10% (w/v) CuSO4, and charred at 180 °C for 10 min, and lipids
were quantitated by photodensitometry (Shimadzu, Kyoto, Japan).
Recovery and Analysis of Covalently Bound Lipids—After sequential
extraction of epidermal samples as described above, pellets were ex-
tracted three times for 5 min at room temperature with methanol
followed by two additional extractions for 2 h with 95% methanol at
60 °C. The final fraction was checked for lipid content. Covalently
bound lipids were released by incubation with 1 ml of 1 M KOH in 95%
methanol for 2 h at 60 °C. Lipids were subsequently recovered by
adding 2 ml of water and 2 ml of chloroform. The chloroform layer was
removed, and the aqueous phase was extracted once more with 2 ml of
chloroform. The organic phases were combined and evaporated under a
stream of nitrogen. Lipids were applied to prewashed (chloroform/meth-
anol 9:1, v/v) thin-layer Silica Gel 60 plates (Merck) and separated
using 23 chloroform/methanol/acetic acid (190:9:1, v/v/v) as developing
solvent. Quantification of lipids was performed as described above. For
quantification of fatty acids, increasing amounts of palmitic acid
(Fluka, Buchs, Switzerland) were applied to the plates.
MALDI Mass Spectrometry of Lipids—Aliquots of lipid extracts were
separated by TLC techniques as described above. Individual sphingo-
lipids were scraped from plates and redissolved in chloroform/methanol
1:1 (v/v). Approximately 50–200 pmol of lipid were mixed with 20 mg of
2,5-dihydroxybenzoic acid (ICN Biochemicals) directly on the target.
Mass spectrometric analysis was performed on a TofSpec E (MicroMass,
Manchester, UK) mass spectrometer operating at an acceleration volt-
age of 20 kV with a 337-nm nitrogen laser. External calibration was
performed using PEG-1000 (Sigma).
Light and Electron Microscopy—Skin samples were taken at au-
topsy, either immediately or 24 h after birth, and processed for light and
electron microscopy. For light microscopy, samples were fixed by im-
mersion in phosphate-buffered paraformaldehyde (4%), embedded in
paraffin, sectioned (5 mm), stained with hematoxylin and eosin, and
photographed with a Zeiss Axioplan microscope. For electron micros-
copy, samples were minced to ,0.5 mm, fixed overnight in HEPES
buffer (0.16 M, pH 7.3) containing glutaraldehyde/formalin (1.25:0.5%)
and 0.1 mM CaCl2, and postfixed in both ruthenium tetroxide, as de-
scribed previously (22), and 2% aqueous osmium tetroxide, each con-
taining 1.5% potassium ferrocyanide. After fixation, all samples were
dehydrated in graded ethanol solutions and embedded in an Epon/
epoxy mixture. Ultrathin sections were examined, with or without
further contrasting with lead citrate, in an electron microscope (Zeiss
10A, Carl Zeiss, Thornwood, NY) operated at 60 kV.
Statistical Analysis—Statistical evaluation of data was performed
using a two-tailed Student’s t test.
RESULTS
Epidermal Sphingolipids in pSAP Knockout Mice—To ad-
dress the question of whether the pSAP product SAP-C is
involved in the processing of epidermal GlcCer to Cer and
therefore important for epidermal barrier formation, we first
determined the GlcCer and Cer levels in the epidermis of pSAP
knockout mice. After extraction, sphingolipids were separated
by TLC and quantitated by photodensitometry. Aliquots of lipid
extracts taken in parallel were used to isolate individual sphin-
golipids by TLC for MALDI mass spectrometric analysis. Al-
though we had proposed likely compositions for sphingolipid
structures, we could not distinguish differences in fatty acid
and sphingoid chain length distribution from masses of intact
molecular ions. In this work, structural data are presented in
accordance with the epidermal Cer terminology proposed by
Motta et al. (23) and modified by Robson et al. (24). Briefly, the
Cer structures are denoted by the composition of the sphingoid
base (either sphingosine (S) or phytosphingosine (P)) and the
N-acyl fatty acid by the presence of a-hydroxy group (A), v-hy-
droxy group (O), or no-hydroxy group (N) and whether the v
position is further acylated (i.e. esterified (E)).
Distinct differences in the epidermal lipid composition were
evident between pSAP-deficent and wild-type animals. First,
the content of each of the three distinct GlcCer fractions that
were readily separated by TLC (see mass spectrometric analy-
sis for structural assignments below) was significantly elevated
in the epidermis of pSAP 2/2 versus wild-type littermates (Fig.
1, A and C). In the absence of pSAP, GlcCer(EOS) accumulated
5.2-fold (p , 1028, n 5 9), whereas the more polar (i.e., lower Rf
value) GlcCer A/B and GlcCer(C16-AS) accumulated 2.1-fold
(p , 1024) and 2.2-fold (p , 0.02), respectively. In heterozygous
mice, which demonstrate nearly 50% reduction in the expres-
sion of pSAP protein (20), only the GlcCer(EOS) fraction
showed significant accumulation (1.4-fold, p , 0.03), whereas
the other GlcCer fractions remained unchanged. These results
suggest not only that the processing of epidermal GlcCers by
acidic b-GlcCerase requires the production of pSAP, and pre-
sumably mature SAP generation, but that the hydrolysis of the
more hydrophobic epidermal GlcCers (e.g. GlcCer(EOS)) is
more dependent upon the presence of SAP-C.
The storage of GlcCers was accompanied with a decrease in
the level of epidermal ceramides. Ceramides were separated
into five fractions (Fig. 1B) and later identified by MALDI mass
spectrometric analysis (see below). With the exception of
Cer(C16-AS), all of the other epidermal ceramides were mod-
estly decreased in the SAP 2/2 epidermis in comparison with
wild-type littermates (by approximately 20%) (Fig. 1D). In con-
trast, the least hydrophobic ceramide, Cer(C16-AS), accumu-
lated 1.3-fold over control (p , 0.05). Moreover, the Cer levels
of heterozygous mouse epidermis were not significantly differ-
ent from normal littermates (Fig. 1D). The diminished levels of
epidermal Cer in conjunction with the preferential accumula-
tion of hydrophobic GlcCer (noted above) strongly suggest a
role for either pSAP itself or a mature SAP, presumably SAP-C,
in the hydrolytic processing of GlcCer-to-Cer in epidermis.
We next identified each of the GlcCer and Cer fractions
separated by TLC. Using MALDI mass spectrometric analysis,
the most hydrophobic glycolipid, GlcCer(EOS), was found to
contain v-OH fatty acids of various chain lengths (C28–C36)
and degrees of saturation with a majority being C32:0 (M 1 Na,
1224.7 atomic mass units) and C34:1 (M 1 Na, 1250.6 atomic
mass units) (Fig. 2A). The v-OH moiety of this GlcCer fraction
is known to be acylated in the epidermis with linoleic acid,
as shown here and previously (25). GlcCer A/B (Fig. 2B)
comprised a complex mixture of GlcCers (i.e. GlcCer(NS)
GlcCer(NP), and GlcCer(C24,26-AS)). Non-hydroxy fatty acids
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with dominant chain length of C24:0, C25:0, and C26:0 were
attached to either sphingosine or phytosphingosine. The less
abundant a-hydroxy fatty acids in GlcCer A/B showed a similar
pattern with C24:0-OH (M 1 Na, 850.4 atomic mass units),
C25:0-OH (M 1 Na, 864.4 atomic mass units), and C26:0-OH
(M 1 Na, 878.4 atomic mass units). The presence of significant
amounts of C25 and other odd-chain fatty acids in epidermal
ceramides has also previously been reported (26, 27). Because
of the differences in molecular polarity, it seems likely that the
upper part of the double band, GlcCer A/B, represents GlcCers
with non-hydroxy fatty acids, whereas the lower part corre-
sponds to the GlcCers containing a-hydroxylated fatty acids.
The most hydrophilic glycolipid, GlcCer(C16-AS), was identi-
fied as a homogenous GlcCer containing mainly a C16:0-OH
fatty acid (M 1 Na, 738.5 atomic mass units, Fig. 2C).
MALDI mass spectrometric analysis of ceramides revealed
sphingoid and fatty acid compositions similar to those found in
their corresponding glucosylceramide precursors as well. With
regard to the ceramide moiety, GlcCer(EOS) appeared to cor-
respond to Cer(EOS) having the same fatty acid pattern, again
with a majority being C32:0 (M 1 Na, 1062.9 atomic mass
units) and C34:1 (M 1 Na, 1088.8 atomic mass units) (Fig. 2E).
Cer(NS) contained different non-hydroxy fatty acids with chain
length between C24 and C26 (Fig. 2F). Cer(NP) appeared to be
hydroxylated in the sphingoid backbone because it comigrated
with synthetic phytoceramide on TLC chromatograms. The
molecular masses indeed demonstrated an additional hydroxyl
group in Cer(NP) together with various degrees of saturation of
long chain fatty acids (Fig. 2G). Cer(C24,26-AS) and Cer(C16-
AS) both were identified as ceramides containing a-hydroxy
fatty acids attached to sphingosine. In Cer(C24,26-AS) C24:
0-OH (M 1 Na, 688.5 atomic mass units), C25:0-OH (M 1 Na,
702.6 atomic mass units), and C26:0-OH (M 1 Na, 716.6 atomic
mass units) fatty acids were found (Fig. 2H). Taken together,
Cer(NS), (NP), and (C24,26-AS) comprised the lipid backbones
of GlcCer A/B. The most hydrophilic ceramide, Cer(C16-AS),
possessed mainly a C16:0-OH fatty acid and therefore corre-
sponds to GlcCer(C16-AS) (Fig. 2D).
Processing of sphingomyelin to Cer by acidic sphingomyeli-
nase (SMase) could also contribute to the pool of Cer available
for barrier formation within the epidermis. A significant in vivo
activation of acidic SMase by SAPs could not be concluded from
lipid profiles of brain and liver from pSAP knockout mice (20).
However, in the epidermis the sphingomyelin level was in-
FIG. 1. Epidermal sphingolipid composition of pSAP knockout mice. One-dimensional TLC separations of polar epidermal lipids (panel
A; PE, phosphatidylethalolamin; PC, phosphatidylcholine; PS, phosphatidylserine, SM, sphingomyelin) and epidermal ceramides (panel B; X1 and
X2, not identified) are shown. Densitometric quantitations of GlcCer (panel C) and Cer (panel D) are given. C and D, data are presented as the
mean 6 S.E. (n $ 7). Note the accumulation of GlcCers, especially of GlcCer(EOS), in the homozygous knockout mice. GlcCer A/B is a complex
mixture of GlcCer(NS), GlcCer(NP), and GlcCer(C24,26-AS). The lipid contents of either heterozygous or homozygous mice differ significantly from
wild-type levels at: ppp, p # 1025; pp, p # 0.01; and p, p # 0.05. n.s., not significant.
Sphingolipid Activator Proteins in Epidermal Barrier Formation11040
FIG. 2. MALDI mass spectrometry of epidermal sphingolipids. Lipids were isolated from either wild-type or pSAP knockout mice by TLC
and analyzed in the positive ion mode. All indicated masses represent sodium adducts of intact molecules. The likely compositions of the most
prominent peaks are indicated. The fatty acids are indicated first followed by the sphingoid bases. The proposed chemical structures of individual
sphingolipids are shown. The lipid backbones of GlcCer A/B are Cer(NS), Cer(NP), and Cer(C24,26-AS).
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creased 1.5-fold over that in wild-type mice (p , 0.02, data not
shown).
Covalently Bound Lipids in pSAP Knockout Mice—Termi-
nally differentiated keratinocytes (corneocytes) are coated by a
monolayer of v-OH ceramides, ester-linked to proteins of the
outer surface of the cornified cell envelope. This lipid-bound
envelope is thought to be essential for either corneocyte cohe-
sion and/or organization of extracellular lipid lamellae (28, 29).
We characterized these lipids obtained after exhaustive prior
extraction of epidermal samples followed by alkaline hydrolysis
(12). To ascertain that the recovered lipids were indeed co-
valently attached, each sample was checked to ensure that
there was no residual extractable lipids before undergoing base
hydrolysis (Fig. 3A, lanes 1, 3, and 5). A mixture of long chain
fatty acids, Cer(OS), and v-OH fatty acids were released from
the wild-type epidermis (Fig. 3A, lane 2). In addition to these
lipids, substantial amounts of GlcCer(OS) were covalently at-
tached to the cornified cell envelope in pSAP 2/2 mice (Fig. 3A,
lane 4). All three v-OH species had the same fatty acid chain
length distribution with a majority being C32:1, C32:0, and
C34:1 as demonstrated by mass spectrometry (Fig. 4). Further-
more, the levels of bound Cer(OS) and v-OH fatty acids in
homozygous knockout mice were significantly decreased to 80%
FIG. 3. Covalently bound lipids in wild-type and pSAP knock-
out mice. Ester-linked epidermal lipids were released by alkaline
hydrolysis and analyzed by TLC. A, representative chromatographical
separation of recovered lipids from either wild-type or pSAP knockout
mice (lanes 2, 4, and 6). Note that the samples were devoid of unbound
lipids before undergoing alkaline hydrolysis (lanes 1, 3, and 5). X, not
identified. B, individual lipid levels were quantified by densitometric
analysis. Data are presented as the mean 6 S.E. (n $ 7). The lipid
contents of either heterozygous or homozygous mice differ significantly
from wild-type levels at: ppp, p # 1025; pp, p # 0.01; p, p # 0.05. n.s., not
significant.
FIG. 4. Mass spectrometry of ester-linked epidermal lipids.
Bound lipids were released by alkaline hydrolysis and isolated using
TLC. Indicated molecular masses represent positively charged sodium
adducts of intact molecules. The likely compositions of the most prom-
inent peaks are indicated. The fatty acids are indicated first, followed
by the sphingoid bases. The proposed chemical structures of individual
lipids are shown. p, unidentified impurity extracted from silica gel.
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(p 5 0.05) and 48% (p 5 0.002) of normal control, respectively.
Comparably low levels of covalently bound GlcCer(OS) could
also be detected in pSAP 1/2 as well as in wild-type epidermis.
In summary, these data show that in pSAP 2/2 mice there is
a switch from a hydrophobic to a more hydrophilic lipid-bound
envelope.
Morphological Alterations in the Epidermis of pSAP Knock-
out Mice—Newborn pSAP knockout mice displayed an ichthy-
otic skin phenotype including a red and wrinkled appearance
previously observed in a more dramatic fashion in the b-
GlcCerase-deficient Gaucher mice (15, 17). These findings are
consistent with a defect in the epidermal permeability barrier
and suggest underlying defects in the critical membrane do-
mains in the stratum corneum. Therefore, to ascertain the
significance of pSAP deficiency in the epidermis, we first ana-
lyzed epidermal sections at the light microscopic level (Fig. 5).
In the homozygous knockout mice, morphological alterations
were limited to the stratum corneum and the stratum lucidum,
which represents the interface between the upper stratum
granulosum and the lower stratum corneum. The thicker stra-
tum lucidum in the knockout mice in comparison with the
wild-type mice could be the result of an accumulation of un-
processed GlcCer. Furthermore, large parts of the stratum
corneum were absent in sections of the knockout animals,
possibly because of reduced mechanical stability resulting from
swelling of intercellular domains.
Alterations in Epidermal Ultrastructure—To further delin-
eate the basis for the cutaneous abnormalities induced by the
deficiency of pSAP in the epidermis, micrographs from pSAP
knockout, heterozygous, and wild-type littermates were com-
pared (Fig. 6). The pSAP-deficient epidermis (2/2) displayed a
striking abnormality in lamellar membrane maturation within
the interstices of the lower-to-middle stratum corneum (Fig. 6,
A and B) when compared with that of normal (Fig. 6C) litter-
mates. The distinctive membrane unit structures seen in the
normal stratum corneum (Fig. 6C) were replaced by arrays of
foreshortened lamellae in loose, discontinuous aggregates in
the pSAP-deficient stratum corneum (Fig. 6, A and B, arrows),
resembling those seen with b-GlcCerase deficiency (14, 15).
Although normal quantities of lamellar bodies were present
and secreted normally in pSAP-deficient epidermis (Fig. 6E,
arrowheads), their internal structure appeared to be altered
from those in heterozygous or normal littermates (Fig. 6D and
inset); individual organelles often appeared enlarged and en-
gorged with non-lamellar, electron-dense material, which in
turn disrupts the internal contents normally seen in wild-type
epidermis. Moreover, the secreted lamellar body-derived con-
tents in the intercellular spaces at the stratum corneum-stra-
tum granulosum interface in pSAP 2/2 animals retained a
compact, spherical pattern (Fig. 6A, asterisks) rather than pro-
gressively unfurling into linear configurations, as occured in
the heterozygous and wild-type stratum corneum. These stud-
ies indicate that a profound deficiency of pSAP does not disrupt
production, trafficking, or secretion of lamellar body contents
into the intercellular domains. Instead, pSAP deficiency results
in major abnormalities in the following: (a) the internal orga-
nization of lamellar body contents; (b) dispersal after secretion;
and (c) extracellular processing of extruded lamellar body con-
tents. Heterozygous animals, although expressing approxi-
mately 50% of the pSAP protein levels (20), did not display
abnormalities in the contents or maturation of the lamellar
body, suggesting that sufficient pSAP is expressed to sustain
the extracellular hydrolytic activity required to generate ma-
ture lamellar membrane organization.
DISCUSSION
In this work, we isolated lipids from murine epidermis and
for the first time presented a complete mass spectrometric
characterization of both epidermal ceramides and correspond-
ing glucosylceramides. Our data on the ceramides are in good
agreement with previous structural characterization of murine
Cer(EOS), Cer(NS), and Cer(C16-AS) (26). Because we exclu-
sively obtained intact molecular ions (by MALDI), the fatty
acid and sphingosine chain length distributions are not dis-
cernable. However, the sphingoid bases from human and pig
epidermal ceramides are known to have limited chain length
heterogeneities between C16 and C22 (27, 30), consistent with
the substrate specificity of epidermal serine palmitoyltrans-
ferase (31). We therefore proposed likely compositions of indi-
vidual sphingolipids. The structural assignment of Cer(NP),
referred to here as phytoceramide, is based both on its mass
spectrum and its comigration on TLC plates with synthetic
phytoceramide. We found similar sphingoid and fatty acid com-
positions of ceramides and corresponding glucosylceramides.
For example, GlcCer(EOS) and Cer(EOS) both exhibited
mainly C32:0 and C34:1 v-OH fatty acids, strongly suggesting
a precursor/product relationship between these two related
epidermal lipids.
Processing of epidermal GlcCers to ceramides by the action
of acidic b-GlcCerase is well known to be essential for cutane-
ous barrier formation and homoeostasis (14–17). In pSAP 2/2
mice, an accumulation of all GlcCers was evident, demonstrat-
ing that optimal epidermal b-GlcCerase activity in vivo re-
quires stimulation by SAPs (i.e. SAP-C). Furthermore, the im-
portance of SAP-C mediation is underscored by the observation
that degradation of the most hydrophobic GlcCer, GlcCer
(EOS), was found to be most impaired in the absence of SAPs.
SAP-C is thought to stimulate b-GlcCerase by an allosteric
mechanism, resulting in trimeric complex formation between
the water-soluble enzyme, the activator protein, and the mem-
brane-associated glycolipid (1, 7). In vitro data have demon-
strated the ability of SAP-C to form complexes with b-Glc-
Cerase in the presence of phosphatidylserine (32, 33). However,
in vivo binding of SAP-C to GlcCers may also contribute to the
stimulation of GlcCer hydrolysis. Indeed, SAP-C has recently
been shown to solubilize membrane-bound GlcCers presum-
FIG. 5. Light micrographs of skin
sections of pSAP knockout mice in
comparison with wild-type mice.
Whole skin was removed from the abdo-
men of either wild-type or homozygous
knockout mice, and paraffin-embedded
thin sections were stained using hematox-
ylin and eosin. SL, stratum lucidum.
Bars, 20 mm.
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ably facilitating their processing by water-soluble enzyme (7).
Despite the massive accumulation of GlcCers, epidermal Cer
levels were only moderately reduced in newborn pSAP 2/2
mice compared with wild-type littermates. One explanation for
the near normal levels of Cer might be increased sphingomye-
lin (SM)-to-Cer hydrolysis. However, the increased SM content
in the pSAP 2/2 mouse epidermis reported here is also of
consequence. In normal epidermis, the levels of both SM and
GlcCer are high in nucleated cells but these lipids are nearly
absent from the stratum corneum (34). Previous results with
b-GlcCerase null allele animals also suggest that the majority
of stratum corneum ceramides are derived from the hydrolysis
of GlcCer precursors (15). The importance of stratum corneum
SMase for barrier homoeostasis has only recently been demon-
strated.2,3 Thus, a portion of the Cer in stratum corneum nor-
mally may derive from SM, or this pathway could be up-regu-
lated in the face of a b-GlcCerase blockade. Moreover, although
SAP-C has been shown to stimulate acidic SMase activity in
vitro (35, 36), the role of SAPs in SM hydrolysis in vivo has not
been adequately addressed. SMase activity is normal in ex-
tracts from dermal fibroblasts isolated from a patient with
pSAP deficiency (8). However, the increased epidermal SM
content in the absence of pSAP expression described here sug-
gests that SAP(s) may have a role in the regulation of epider-
mal SMase activity. Whether increased epidermal SM contrib-
utes to the stratum corneum pathology remains to be
determined.
In principle, b-GlcCerase can degrade GlcCer without
SAP-C. Furthermore, an excess of b-GlcCerase activity is pres-
ent in normal epidermis, as Gaucher heterozygous animals
with approximately 50% of normal activity do not exhibit SC or
epidermal pathology (15). Therefore, it seems likely that during
embryonic development substantial amounts of ceramides are
provided by slow hydrolysis of GlcCer without any loss by
desquamation starting after birth. Finally, ceramides could
also derive directly from de novo synthesis under pathological
conditions or even physiologically. The most polar ceramide,
Cer(C16-AS), was found to be elevated in the absence of pSAP,
suggesting a compensatory capacity of sphingolipid biosyn-
thetic pathways in keratinocytes.
It is well known that a monolayer of v-OH-Cer is covalently
attached to the surface of corneocytes connecting proteins of
the cornified cell envelope to hydrophobic intercellular lipid
2 E. Proksch and J. M. Jensen, personal communication.
3 W. M. Holleran and P. M. Elias, unpublished observation.
FIG. 6. Ultrastructure of pSAP
knockout epidermis in comparison
with wild-type littermates. In the
lower to mid-SC from pSAP-deficient
(2/2) mouse epidermis, conventional os-
mium tetroxide staining reveals extruded
lamellar body contents to be highly disor-
ganized (A, open arrows), with persist-
ence of osmiophilic material in the inter-
stices out to at least the fourth to fifth SC
cell layers (A, stars), an area routinely
undeposited by osmophilic material in
normal wild-type SC tissues (not shown).
Moreover, extruded lamellar body con-
tents retain a spherical pattern in the
interstices (A, asterisks), suggesting that
linearization of lamellar body-derived la-
mellae is delayed or defective. Ruthenium
staining (22) further reveals that the
pSAP-deficient interstices (B, between ar-
rows) lack the regular, compact pattern of
lamellar membranes observed in normal,
pSAP-replete SC (C, between open ar-
rows). Although significant quantities of
lamellar bodies are formed in pSAP-defi-
cient epidermis (E, arrowheads), the con-
tents have a more condensed appearance
when compared with normal wild-type lit-
termates (D, arrowheads; and inset, aster-
isk shows an enlarged image of a lamellar
body from normal epidermis). Bars repre-
sent 0.25 (A–E) and 0.125 mm (D, inset)
with final image magnifications (all are
3103) of: A, 46.6; B, 68.8; C, 62.5; D, 64.0;
E, 44.8; D, inset, 120. sg, stratum
granulosum.
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lamellae (12). Recently, some structural proteins within the
epidermis have been shown to be esterified at Glu or Gln
residues with Cer(OS) (13). Although little is known about the
attachment of lipids to proteins of the epidermal cornified cell
envelope, it was assumed that free Cer(EOS) are the direct
precursors of bound Cer(OS). We have analyzed covalently
bound epidermal lipids in pSAP knockout mice. Most impor-
tantly, in pSAP 2/2 mice a novel lipid was recovered and
identified as GlcCer(OS), which had the same fatty acid chain
length distribution as found in the bound Cer(OS) and in v-OH
fatty acids as well. Obviously, these lipids are metabolically
related to each other. It has been an open question whether
Cer(OS) is bound to amino acid side chains either via the
v-hydroxyl group or via C1 of sphingoid bases. Because Glc-
Cer(OS) cannot be bound through C1, where the glucose moiety
is located, this finding provides evidence that at least a portion
of all three v-OH species are attached to the cornified cell
envelope via the terminal v-hydroxyl group.
Because we detected small amounts of bound GlcCer(OS) in
both pSAP 1/2 and wild-type mice, this phenomenon appears
to be physiologically important. In our model, lamellar body-
derived GlcCer(EOS) is, in part, utilized by an enzyme that
exchanges esterified linoleic acid against the side chain of a
glutamate residue. Resulting bound GlcCer(OS) would subse-
quently be deglycosylated to bound Cer(OS) by SAP-C-assisted
b-GlcCerase and then hydrolyzed to bound v-OH fatty acid and
free sphingosine by SAP-D-assisted ceramidase. This metabolic
relationship is supported by identical fatty acid chain length
distribution in all three v-OH species. Stimulation of lipid-
bound envelope-associated processing of lipids by hydrolytic
enzymes would mechanistically work by an allosteric enzyme
activation rather than by solubilization of lipids, which are
covalently attached and therefore cannot be lifted by an acti-
vator protein. On the other hand, it cannot be excluded that
free Cer(EOS) would also be transferred to proteins of the
cornified cell envelope by an enzyme, which utilizes either
Cer(EOS) or GlcCer(EOS). In pSAP 2/2 mice, levels of bound
v-OH fatty acid and Cer(OS) were significantly decreased to 48
and 80% of control, respectively. These data support the con-
cept that bound GlcCer(OS) is the likely precursor of bound
Cer(OS) and v-OH fatty acid. Formation of the latter is more
severely impaired than formation of Cer(OS) because, in addi-
tion to reduced substrate concentration due to SAP-C defi-
ciency, ceramidase is missing its physiological activators,
SAP-D (37) and SAP-C.4 However, it needs to be clarified in
future studies whether covalently attached Cer(OS) and Glc-
Cer(OS) are indeed substrates for ceramidase and b-GlcCerase,
respectively.
Finally, morphological alterations in the epidermis of pSAP
2/2 mice were significant and reminiscent of the alterations
observed in b-GlcCerase-deficient Gaucher epidermis. Electron
microscopy revealed a striking abnormality in SC lamellar
membrane organization. Moreover, light micrographs revealed
a partial loss of stratum corneum in pSAP 2/2 mice, which
may reflect decreased SC coherence. Thus, the accumulation of
the more hydrophilic glucosylated Cer species, rather than Cer,
within the extractable SC lipid and/or the lipid-bound envelope
is likely responsible for the observed alterations in epidermal
structure. However, since pSAP also exists as a surface com-
ponent of neuronal cells (38), other potential functions for this
protein in the epidermis, beyond its precursor role, still need to
be explored.
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